Original language | English |
---|---|
Pages (from-to) | 479-480 |
Number of pages | 2 |
Journal | Schizophrenia Research |
Volume | 208 |
DOIs | |
State | Published - Jun 2019 |
Externally published | Yes |
Bibliographical note
Funding Information:This work was supported by a VA MIRECC Pala Pilot Grant and a grant from the American Psychiatric Foundation to MCD. NAC and matching placebo capsules were generously donated by Vital Nutrients, Inc. Vital Nutrients, Inc., had no further role in the design, analysis, interpretation, or decision in publication of this study. For Michael C. Davis, participation occurred prior to his current position. The contents herein do not represent the views of the U.S. Department of Veterans Affairs, the U.S. Food and Drug Administration, or the United States Government.
Funding
This work was supported by a VA MIRECC Pala Pilot Grant and a grant from the American Psychiatric Foundation to MCD. NAC and matching placebo capsules were generously donated by Vital Nutrients, Inc. Vital Nutrients, Inc., had no further role in the design, analysis, interpretation, or decision in publication of this study. For Michael C. Davis, participation occurred prior to his current position. The contents herein do not represent the views of the U.S. Department of Veterans Affairs, the U.S. Food and Drug Administration, or the United States Government.
Funders | Funder number |
---|---|
American Psychiatric Foundation |